(redirected from Baxter International Inc.)
BAXBCL (B Cell Lymphoma)-Associated X
BAXBaxter International Inc. (stock symbol; Deerfield, IL)
BAXBankers' Acceptance (Canadian futures)
BAXBCL2-Associated X Protein
BAXBurlington Air Express
BAXBrooklyn Arts Exchange (New York)
BAXBarnaul, Russia - Barnaul Airport (Airport Code)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Release date- 04092019 - Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its third quarter 2019 financial results on Thursday, October 24, 2019, at 7:30 a.m.
Harry Kraemer, former chairman and chief executive officer of Baxter International Inc., will serve as chairman of the board.
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced an increase in the company's quarterly cash dividend, to a rate of $0.22 per share of common stock.
US-based medical products company Baxter International Inc. (NYSE: BAX) has completed the acquisition of two hemostat and sealant products from UK-based pharmaceutical company Mallinckrodt plc (NYSE: MNK), the company said.
(NASDAQ: SSH) has acquired the Aquadex product line from an indirect subsidiary of Illinois-based renal and hospital products portfolio supplier Baxter International Inc. (NYSE: BAX), the company said.
* Key players covered include Smiths Medical, Hospira, Inc., Halyard Health, Inc., Baxter International Inc. and Others.
Companies Mentioned in this Report: Smiths Medical, Halyard Health, Inc., Baxter International Inc., Hospira, Inc., Calmare Therapeutics Incorporated"
This common stock offering is currently owned by the company's former parent company, Baxter International Inc.
-- based Baxter International Inc. has invited Boston Scientific Corp.
Baxter International Inc. received FDA approval for its supplemental drug application to establish its Sabinanigo, Spain, facility as an approved manufacturing site for 0.9% Sodium Chloride Injection, USP, for the U.S.
-- Baxter International Inc. has announced plans to create two separate, independent global health care companies, one focused on developing and marketing biopharmaceuticals and the other focused on medical products.